<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601521</url>
  </required_header>
  <id_info>
    <org_study_id>2015P000002/MGH</org_study_id>
    <nct_id>NCT02601521</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.</brief_title>
  <acronym>PiHQ</acronym>
  <official_title>Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Partners HealthCare, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Specific Aim: To conduct a randomized controlled trial among permanent employees of Partners&#xD;
      HealthCare, Inc., and their adult dependents, who are current tobacco smokers. The trial will&#xD;
      compare two interventions designed to help smokers stop using tobacco: (1) External Coaching&#xD;
      Program (Standard Care) and (2) Internal Coaching Program, a chronic disease management&#xD;
      strategy for treating tobacco use and dependence.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">March 2020</completion_date>
  <primary_completion_date type="Actual">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tobacco abstinence for the past 30 days</measure>
    <time_frame>6 months after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tobacco abstinence for the past 30 days</measure>
    <time_frame>3 months after enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tobacco abstinence for the past 30 days</measure>
    <time_frame>12 months after enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quit attempt</measure>
    <time_frame>Intentional tobacco abstinence for at least 24 hours since enrollment</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of use of tobacco cessation pharmacotherapy</measure>
    <time_frame>at 3 months and at 6 months after enrollment</time_frame>
    <description>Includes any FDA-approved product (nicotine patch, gum, lozenge, inhaler, nasal spray or bupropion or varenicline</description>
  </other_outcome>
  <other_outcome>
    <measure>Smoking cessation counseling contacts</measure>
    <time_frame>at 3 months and at 6 months after enrollment</time_frame>
    <description>Number of telephone calls with an internal or external tobacco coach to address smoking cessation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Internal coaching program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The internal coaching program uses a chronic disease management strategy to treat tobacco use and dependence. The program provides evidence-based treatment consisting of up to 12 months of services from a tobacco coach based at Partners HealthCare. The tobacco coach offers (1) repeated smoking cessation counseling delivered by proactive telephone calls, emails, and interactive voice response [automated phone calls] and (2) facilitated access to a new Partners HealthCare Inc., health insurance benefit that provides access to all FDA-approved smoking cessation medications without copay or prior approval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>External coaching program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The external coaching program consists of referral to the Massachusetts Tobacco Control Program's Smokers Helpline, a free program offering multi-session proactive telephone counseling for 3 months to individuals who are ready to quit smoking. Individuals in this arm also receive information about Partners HealthCare, Inc.'s new health insurance benefit that provides access to all FDA-approved smoking cessation medications without copay or prior approval.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internal tobacco coach</intervention_name>
    <description>The internal coaching program will provide cognitive-behavioral counseling and medication adherence support for smokers who are ready to quit in the next 3 months It consists of:&#xD;
Telephone counseling by the Tobacco Coach (8 calls over 12 weeks). supplemented by automated phone calls using interactive voice response. At each IVR contact, smokers can request a call back from the Tobacco Coach. Smokers who are not quit after 3 months can restart into the 12-week counseling program.&#xD;
The Tobacco Coach will assist smokers in choosing pharmacotherapy and in obtaining a prescription from the smoker's physician.&#xD;
Support and monitoring for 12 months using automated phone calls. If relapse occurs, the smoker will have the option to return to the active 12-week program.</description>
    <arm_group_label>Internal coaching program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>External tobacco coach</intervention_name>
    <description>Referral to Massachusetts Smokers Helpline (telephone quitline operated by the Massachusetts Tobacco Control Program) for proactive telephone counseling.</description>
    <arm_group_label>External coaching program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current permanent employee of Partners Healthcare, Inc. or their adult dependent&#xD;
&#xD;
          -  Current tobacco smoker (smoked a cigarette, even a puff, in the past 30 days)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Temporary, per diem or former employee of Partners Healthcare, Inc.&#xD;
&#xD;
          -  Plan to leave Partners employment in the next 12 months&#xD;
&#xD;
          -  Inability to give informed consent or participate in counseling due to serious&#xD;
             psychiatric disorder or cognitive disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy A Rigotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 9, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2015</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Nancy A. Rigotti</investigator_full_name>
    <investigator_title>Professor of Medicine, Harvard Medical School</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

